Zobrazeno 1 - 10
of 170
pro vyhledávání: '"Tong Yu Lin"'
Autor:
Dok Hyun Yoon, Junning Cao, Tsai-Yun Chen, Koji Izutsu, Seok Jin Kim, Yok Lam Kwong, Tong Yu Lin, Lim Soon Thye, Bing Xu, Deok Hwan Yang, Won Seog Kim
Publikováno v:
Journal of Hematology & Oncology, Vol 13, Iss 1, Pp 1-11 (2020)
Abstract Background Mantle cell lymphoma (MCL) is a B cell malignancy that can be aggressive and with a poor prognosis; the clinical course is heterogeneous. The epidemiology of MCL in Asia is not well documented but appears to comprise 2–6% of all
Externí odkaz:
https://doaj.org/article/93933c9342694818b345d0e5ca879f93
Autor:
William Townsend, Wolfgang Hiddemann, Christian Buske, Guillaume Cartron, David Cunningham, Martin J.S. Dyer, John G. Gribben, Elizabeth H. Phillips, Martin Dreyling, John F. Seymour, Andrew Grigg, Judith Trotman, Tong-Yu Lin, Xiao-Nan Hong, Dirk Kingbiel, Tina G. Nielsen, Andrea Knapp, Michael Herold, Robert Marcus
Publikováno v:
HemaSphere, Vol 7, Iss 7, p e919 (2023)
The phase III GALLIUM trial assessed the safety and efficacy of obinutuzumab-based versus rituximab-based immunochemotherapy in patients with previously untreated follicular lymphoma (FL) or marginal zone lymphoma (MZL). At the primary analysis, the
Externí odkaz:
https://doaj.org/article/54ee041689654f5486a8b741a193c36c
Autor:
Mei-ting Chen, Fei Pan, Yung-chang Chen, Wei Zhang, Hui-juan Lv, Zhao Wang, Huang-ming Hong, Xiao-jie Fang, Ya-wen Wang, Tao Pan, Li-qun Zou, Hong-qiang Guo, Ke Xie, Li-min Chen, Xiao-qian Li, Yu-yi Yao, Ze-geng Chen, Hua-wei Weng, Xu-dong Li, Yuan-yuan Shen, Hui Zhou, Hong-wei Xue, Hui-lai Zhang, He Huang, Tong-yu Lin
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-11 (2022)
Abstract Background Adult sporadic Burkitt lymphoma (BL) is a rare but highly aggressive subtype of lymphoma which lacks its own unique prognostic model. Systemic inflammatory biomarkers have been confirmed as prognostic markers in several types of m
Externí odkaz:
https://doaj.org/article/085eb186ea544bb4a14ce0b595e4d080
Autor:
Li-Yang Hu, Xiao-Lu Xu, Hui-Lan Rao, Jie Chen, Ren-Chun Lai, Hui-Qiang Huang, Wen-Qi Jiang, Tong-Yu Lin, Zhong-Jun Xia, Qing-Qing Cai
Publikováno v:
Chinese Journal of Cancer, Vol 36, Iss 1, Pp 1-11 (2017)
Abstract Background The programmed cell death-1 (PD-1)/programmed cell death-ligand 1 (PD-L1) pathway inhibits the activation of T cells and plays a crucial role in the negative regulation of cellular and humoral immune responses. Diffuse large B-cel
Externí odkaz:
https://doaj.org/article/31ade90af9814fb98574f36ebca3d306
Autor:
Qing-Qing Cai, Dan Xie, Tie-Bang Kang, Li-Yan Song, Guo-Wei Li, Lan Hai, Xue-Yi Pan, Zhong-Jun Xia, Wen-Jun He, Hong-Yi Gao, Ying Zhang, Yi-Rong Jiang, Chang-Lu Hu, Yong Zhu, Xiang-Ling Meng, Ying Zhou, Qiao-Nan Guo, Jun Rao, Zhi-Gang Zhu, Hui Liu, Wei Sang, Cai Sun, Wei Dong, Xiao-Dong Chen, Yue-Rong Shuang, Kun Yi, Xi-Na Lin, Xia Gu, Kun Ru, Qi Sun, Run-Fen Cheng, Qiong-Li Zhai, Chun-Kui Shao, Qiong Liang, Qiong-Lan Tang, Zhi-Hua Li, Bing Liao, Juan Li, Xiao-Liang Lan, Li Liang, Li-Ye Zhong, Fen Zhang, Fang Liu, Mei Li, Hui-Lan Rao, Shu-Yun Ma, Tong-Yu Lin, Hui-Qiang Huang, Xi Zhang, Yan-Hui Liu, Wei-Juan Huang, Liang Wang, Ning Su, Xiao-Peng Tian
Supplementary Figure S8
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a06e2168900fc487ee7a47e8daa6897d
https://doi.org/10.1158/1078-0432.22475070
https://doi.org/10.1158/1078-0432.22475070
Autor:
Qing-Qing Cai, Dan Xie, Tie-Bang Kang, Li-Yan Song, Guo-Wei Li, Lan Hai, Xue-Yi Pan, Zhong-Jun Xia, Wen-Jun He, Hong-Yi Gao, Ying Zhang, Yi-Rong Jiang, Chang-Lu Hu, Yong Zhu, Xiang-Ling Meng, Ying Zhou, Qiao-Nan Guo, Jun Rao, Zhi-Gang Zhu, Hui Liu, Wei Sang, Cai Sun, Wei Dong, Xiao-Dong Chen, Yue-Rong Shuang, Kun Yi, Xi-Na Lin, Xia Gu, Kun Ru, Qi Sun, Run-Fen Cheng, Qiong-Li Zhai, Chun-Kui Shao, Qiong Liang, Qiong-Lan Tang, Zhi-Hua Li, Bing Liao, Juan Li, Xiao-Liang Lan, Li Liang, Li-Ye Zhong, Fen Zhang, Fang Liu, Mei Li, Hui-Lan Rao, Shu-Yun Ma, Tong-Yu Lin, Hui-Qiang Huang, Xi Zhang, Yan-Hui Liu, Wei-Juan Huang, Liang Wang, Ning Su, Xiao-Peng Tian
Supplementary Table S7
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::030a7cc54e88c04956334c6240cebfaf
https://doi.org/10.1158/1078-0432.22475040.v1
https://doi.org/10.1158/1078-0432.22475040.v1
Autor:
Qing-Qing Cai, Dan Xie, Tie-Bang Kang, Li-Yan Song, Guo-Wei Li, Lan Hai, Xue-Yi Pan, Zhong-Jun Xia, Wen-Jun He, Hong-Yi Gao, Ying Zhang, Yi-Rong Jiang, Chang-Lu Hu, Yong Zhu, Xiang-Ling Meng, Ying Zhou, Qiao-Nan Guo, Jun Rao, Zhi-Gang Zhu, Hui Liu, Wei Sang, Cai Sun, Wei Dong, Xiao-Dong Chen, Yue-Rong Shuang, Kun Yi, Xi-Na Lin, Xia Gu, Kun Ru, Qi Sun, Run-Fen Cheng, Qiong-Li Zhai, Chun-Kui Shao, Qiong Liang, Qiong-Lan Tang, Zhi-Hua Li, Bing Liao, Juan Li, Xiao-Liang Lan, Li Liang, Li-Ye Zhong, Fen Zhang, Fang Liu, Mei Li, Hui-Lan Rao, Shu-Yun Ma, Tong-Yu Lin, Hui-Qiang Huang, Xi Zhang, Yan-Hui Liu, Wei-Juan Huang, Liang Wang, Ning Su, Xiao-Peng Tian
Purpose:Adults with T-cell lymphoblastic lymphoma (T-LBL) generally benefit from treatment with acute lymphoblastic leukemia (ALL)-like regimens, but approximately 40% will relapse after such treatment. We evaluated the value of CpG methylation in pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9b213781f5ba30c7bc4c3c8d14265f3b
https://doi.org/10.1158/1078-0432.c.6528984
https://doi.org/10.1158/1078-0432.c.6528984
Autor:
Qing-Qing Cai, Dan Xie, Tie-Bang Kang, Li-Yan Song, Guo-Wei Li, Lan Hai, Xue-Yi Pan, Zhong-Jun Xia, Wen-Jun He, Hong-Yi Gao, Ying Zhang, Yi-Rong Jiang, Chang-Lu Hu, Yong Zhu, Xiang-Ling Meng, Ying Zhou, Qiao-Nan Guo, Jun Rao, Zhi-Gang Zhu, Hui Liu, Wei Sang, Cai Sun, Wei Dong, Xiao-Dong Chen, Yue-Rong Shuang, Kun Yi, Xi-Na Lin, Xia Gu, Kun Ru, Qi Sun, Run-Fen Cheng, Qiong-Li Zhai, Chun-Kui Shao, Qiong Liang, Qiong-Lan Tang, Zhi-Hua Li, Bing Liao, Juan Li, Xiao-Liang Lan, Li Liang, Li-Ye Zhong, Fen Zhang, Fang Liu, Mei Li, Hui-Lan Rao, Shu-Yun Ma, Tong-Yu Lin, Hui-Qiang Huang, Xi Zhang, Yan-Hui Liu, Wei-Juan Huang, Liang Wang, Ning Su, Xiao-Peng Tian
Supplementary Figure legend
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7064785e323e14b278d01d8c2ec1ed5a
https://doi.org/10.1158/1078-0432.22475064.v1
https://doi.org/10.1158/1078-0432.22475064.v1
Autor:
Xiao-Peng Tian, Yu-Chen Zhang, Ning-Jing Lin, Liang Wang, Zhi-Hua Li, Han-Guo Guo, Shu-Yun Ma, Ming-Jie An, Jing Yang, Yu-Heng Hong, Xian-Huo Wang, Hui Zhou, Ya-Jun Li, Hui-Lan Rao, Mei Li, Shao-Xuan Hu, Tong-Yu Lin, Zhi-Ming Li, He Huang, Yang Liang, Zhong-Jun Xia, Yue Lv, Yu-Ying Liu, Zhao-Hui Duan, Qing-Yu Chen, Jin-Ni Wang, Jun Cai, Ying Xie, Choon-Kiat Ong, Fang Liu, Yan-yan Liu, Zheng Yan, Liang Huang, Rong Tao, Wen-Yu Li, Hui-Qiang Huang, Qing-Qing Cai
Publikováno v:
Cell Reports Medicine. 4:100859
Autor:
Seok Jin Kim, Dok Hyun Yoon, Deok Hwan Yang, Bing Xu, Koji Izutsu, Lim Soon Thye, Tong Yu Lin, Junning Cao, Tsai Yun Chen, Won Seog Kim, Yok-Lam Kwong
Publikováno v:
Journal of Hematology & Oncology, Vol 13, Iss 1, Pp 1-11 (2020)
Journal of Hematology & Oncology
Journal of Hematology & Oncology
Background Mantle cell lymphoma (MCL) is a B cell malignancy that can be aggressive and with a poor prognosis; the clinical course is heterogeneous. The epidemiology of MCL in Asia is not well documented but appears to comprise 2–6% of all lymphoma